🔥Updated treatment recommendation for third-line treatment in advanced colorectal cancer from the ESMO Metastatic Colorectal Cancer Living Guideline Annals of Oncology doi.org/10.1016/j.anno… 👉TAS is recommended in pts pretreated with 5-Fu, oxaliplatin, irinotecan & biologics

Another step forward 👊🏻😊

Mark Soliman, MD, FACS, FASCRS kicking us off for #occ23 Fantastic lineup ahead of speakers. Look forward to the discussions! Matthew Albert George Nassif Jr DO FACS FASCRS John Monson MD FRCS FACS FASCRS Ahmed Zakari AdventHealth Central Florida

CheckMate-8HW Meets Primary End Points With Nivolumab/Ipilimumab in mCRC targetedonc.com/view/checkmate… via @targetedonc #colorectal #cancer #immunotherapy Bristol Myers Squibb #CancerResearch #MSI-high #clinicaltrials

Congrats💥for great presentation on behalf THE BESPOKE ⁦Pashtoon Kasi MD, MS⁩ All participants & co-authors ⁦AdventHealth Central Florida⁩ ⁦Mohamedtaki A. Tejani⁩

Excited to share Save the Date for our AdventHealth Central Florida symposium focused on Liver, Pancreas and Biliary Tumors! A highly multidisciplinary panel of speakers this year including 🌟🌟 Arndt Vogel and Syed A. Ahmad as our headliners 🌟🌟 Ahmed Zakari Ryan William Day, MD 🌴🌴

Phase I #clinicaltrial #earlydrugdevelopment update from AdventHealth Central Florida #cancer institute, #Orlando/Celebration #Florida -Our rapidly growing Phase I Clinical Research Unit offers new cutting-edge #cancer therapies to the highly diverse and expanding community of central

MRI-guided stereotactic ablative body radiotherapy vs CT-guided percutaneous irreversible electroporation for locally advanced #PDAC The Lancet Gastroenterology & Hepatology doi.org/10.1016/S2468-… 🔎CROSSFIRE phs-II 👉No difference in OS 🧐Wow, interesting concepts, "temporary DCR"... ESMO - Eur. Oncology

Getting excited for April 14! From HAI pumps to liver transplant - all up for discussion with diverse speakers/panelists. Hope to see many of you there! AdventHealth Central Florida Ahmed Zakari

Our Second GI Symposia with Focus Hepatobiliary Cancers and Evolving Liver Surgery. Dr. Tejani and I Co-moderating an excellent panel of Speakers. Outstanding updates by DrVogel BTC Rx to Genomic Profiling Dr . S. Ahmad liver surgery on met CRC #Arndtvogel #SyedAhmad5

Happy Mother’s Day to my beautiful wife and all Moms out there😍😍🎊

Not surprising 😊😊👍

Amazing , confirmatory outcomes 😍!! Ty Arndt for summarizing it👊

🔥off the press: nal-IRI + 5-FU vs 5-Fu in cholangiocarcinoma previously treated with gemcitabine-based therapies The Lancet Gastroenterology & Hepatology 🔎NALIRICC phs 2, 100 pts 👉Disappointing, no benefit w/ nal-IRI 🧐Meta-analysis with NIFTY will come.. 👇my author link: authors.elsevier.com/sd/article/S24…

Hmmm 😔 disappointing

Before leaving Orlando last month, the Brazilian national team spent time spreading warmth and support to families at AdventHealth for Children.

Here we go! Best of ASCO Day 2 kicks off. Fantastic speakers coming up. AdventHealth Central Florida

🙏🙏🙏Mohamedtaki A. Tejani AdventHealth Central Florida for hosting a fantatic #BestofASCO ASCO meeting in ☀️☀️Orlando. Great meeting colleagues and discuss updates in #PancreaticCancer and #BiliaryTractCancer presented at #ASCO24

Distinct clinical outcomes & biological features of specific KRAS mutants in human pancreatic cancer Cancer Cell doi.org/10.1016/j.ccel… 👉KRASG12R enriched in early stage w/ reduced nodal disease + distant recurrence 👉improved OS 🧐 Supports KRAS mutational testing in #PDAC